Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-10-23

FDA Approved: KEPPRA — Supplemental Application (UCB, Inc.)

View source ↗

Summary

FDA approved a supplemental application for KEPPRA (levetiracetam) submitted by UCB, Inc. The approval updates the product labeling and may expand established i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Keppra (levetiracetam)

Snippet

SUPPL AP for KEPPRA (LEVETIRACETAM)